etoposide has been researched along with Carcinoma, Ehrlich Tumor in 21 studies
*Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (38.10) | 18.7374 |
| 1990's | 7 (33.33) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Harkes, M; Homan, B; Malingré, TM; Pras, N; Van Uden, W; Wichers, HJ; Woerdenbag, HJ | 1 |
| Ahmed, AAS; Binsuwaidan, R; El Sayed, IET; Elmongy, EI; Hassan, EA; Nofal, AE; Sakr, M; Tousson, E | 1 |
| Babbar, AK; Chaudhari, K; Manjappa, AS; Mathur, R; Mishra, AK; Murthy, RS; Pimple, S; Rajyaguru, T; Ukawala, M | 1 |
| Dwarakanath, BS; Gupta, S; Mathur, R | 1 |
| Alam, SM; Basu, S; Jha, T; Maji, T; Roy, DK; Samanta, S | 1 |
| Fry, DW; Goldman, ID; Yalowich, JC | 1 |
| Dimitriadis, K; Schmidt, CG; Schütte, J; Seeber, S | 1 |
| Goldman, ID; Yalowich, JC | 1 |
| Achterrath, W; Crooke, ST; Osieka, R; Schmidt, CG; Seeber, S | 1 |
| Seeber, S | 1 |
| Hansen, HH; Holm, B; Jensen, PB; Sehested, M | 1 |
| Anachkova, B; Lallev, A; Russev, G | 1 |
| Holm, B; Jensen, PB; Sehested, M | 1 |
| Bogush, TA; Chmutin, EF; Syrkin, AB | 1 |
| Eriksen, J; Friche, E; Litman, T; Maare, C; Nielsen, D; Skovsgaard, T | 1 |
| Eriksen, J; Litman, T; Maare, C; Nielsen, D; Skovsgaard, T | 1 |
| Demant, EJ; Friche, E; Jensen, PB; Sehested, M | 1 |
| Hines, LH; White, JC; Wright, SE | 1 |
| White, JC; Wright, SE | 1 |
| Hines, LH; Rathmell, JP; White, JC | 1 |
| Nishikawa, K; Okamoto, K; Seki, T; Shibasaki, C; Takahashi, K; Uchida, T | 1 |
21 other study(ies) available for etoposide and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Isolation, purification, and cytotoxicity of 5-methoxypodophyllotoxin, a lignan from a root culture of Linum flavum.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Ehrlich Tumor; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Mice; Molecular Structure; Plants; Podophyllotoxin; Tumor Cells, Cultured | 1992 |
Impact of Synthesized Indoloquinoline Analog to Isolates from
Topics: Animals; Carcinoma, Ehrlich Tumor; Chemical and Drug Induced Liver Injury; Cryptolepis; DNA Topoisomerases, Type II; Etoposide; Female; Mice; Molecular Docking Simulation; Neoplasms; Tumor Necrosis Factor-alpha | 2023 |
Investigation on design of stable etoposide-loaded PEG-PCL micelles: effect of molecular weight of PEG-PCL diblock copolymer on the in vitro and in vivo performance of micelles.
Topics: Animals; Carcinoma, Ehrlich Tumor; Drug Design; Drug Stability; Ethylene Oxide; Etoposide; Female; Lactones; Mice; Mice, Inbred BALB C; Micelles; Molecular Weight; Treatment Outcome; X-Ray Diffraction | 2012 |
The glycolytic inhibitor 2-deoxy-D-glucose enhances the efficacy of etoposide in ehrlich ascites tumor-bearing mice.
Topics: Animals; Antimetabolites; Antineoplastic Agents, Phytogenic; Carcinoma, Ehrlich Tumor; Cell Cycle; Cell Proliferation; Deoxyglucose; DNA Damage; Drug Interactions; Etoposide; Mice; Neoplasms, Experimental | 2005 |
Chemoimmunotherapeutic approach to prolonged survival time in combination with immunization and glutamic Acid derivatives with antitumor activity in tumor-bearing mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cancer Vaccines; Carcinoma, Ehrlich Tumor; Combined Modality Therapy; Etoposide; Female; Glutamates; Immunization; Immunotherapy; Mice; Structure-Activity Relationship; Survival Analysis; Tissue Extracts | 2007 |
Teniposide (VM-26)- and etoposide (VP-16-213)-induced augmentation of methotrexate transport and polyglutamylation in Ehrlich ascites tumor cells in vitro.
Topics: Animals; Biological Transport; Carcinoma, Ehrlich Tumor; Cells, Cultured; Chlorides; Etoposide; Glucose; Kinetics; Methotrexate; Mice; Peptides; Podophyllotoxin; Polyglutamic Acid; Teniposide; Vincristine; Water | 1982 |
Experimental basis and clinical experience with non-cross-resistant combinations in solid tumours.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Ehrlich Tumor; Carcinoma, Small Cell; Cell Line; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Humans; Ifosfamide; Male; Naphthacenes; Sarcoma; Teratoma; Testicular Neoplasms; Vinca Alkaloids; Vincristine | 1984 |
Analysis of the inhibitory effects of VP-16-213 (etoposide) and podophyllotoxin on thymidine transport and metabolism in Ehrlich ascites tumor cells in vitro.
Topics: Animals; Biological Transport; Carcinoma, Ehrlich Tumor; Chromatography, High Pressure Liquid; DNA Replication; Etoposide; Kinetics; Male; Mice; Podophyllotoxin; Thymidine; Tritium | 1984 |
In vivo resistance towards anthracyclines, etoposide, and cis-diamminedichloroplatinum(II).
Topics: Animals; Carcinoma, Ehrlich Tumor; Cisplatin; Daunorubicin; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Kinetics; Mice; Podophyllotoxin; Structure-Activity Relationship | 1982 |
Model studies of etoposide resistance.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Ehrlich Tumor; Cell Line; Drug Resistance; Etoposide; Naphthacenes; Podophyllotoxin | 1982 |
In vivo inhibition of etoposide-mediated apoptosis, toxicity, and antitumor effect by the topoisomerase II-uncoupling anthracycline aclarubicin.
Topics: Aclarubicin; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Ehrlich Tumor; DNA Topoisomerases, Type II; Etoposide; Female; Male; Mice; Mice, Inbred DBA; Tumor Stem Cell Assay | 1994 |
Effect of ionizing radiation and topoisomerase II inhibitors on DNA synthesis in mammalian cells.
Topics: Amsacrine; Animals; Carcinoma, Ehrlich Tumor; DNA; DNA Repair; DNA Replication; DNA, Mitochondrial; Etoposide; Gamma Rays; Leukemia, Erythroblastic, Acute; Mice; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1993 |
ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
Topics: Amsacrine; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Carcinoma, Ehrlich Tumor; Central Nervous System Neoplasms; DNA Topoisomerases, Type II; Etoposide; Female; Injections, Intraperitoneal; Lethal Dose 50; Leukemia L1210; Male; Mice; Mice, Inbred DBA; Paclitaxel; Razoxane; Structure-Activity Relationship | 1996 |
[The effect of topoisomerase II inhibitor, vepesid, on binding of doxorubicin with DNA in tumor cells sensitive to anthracycline].
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Ehrlich Tumor; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Leukemia P388; Mice; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1997 |
Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide.
Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Biological Transport; Carcinoma, Ehrlich Tumor; Cell Size; Daunorubicin; DNA Topoisomerases, Type II; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Immunoassay; Mice; Multidrug Resistance-Associated Proteins; Tumor Cells, Cultured | 2000 |
Expression of P-glycoprotein and multidrug resistance associated protein in Ehrlich ascites tumor cells after fractionated irradiation.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Carcinoma, Ehrlich Tumor; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Glutathione; Mice; Neoplasm Proteins; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Tumor Stem Cell Assay; Verapamil; Vincristine | 2001 |
Relationship of VP-16 to the classical multidrug resistance phenotype.
Topics: Affinity Labels; Animals; Carbon Radioisotopes; Carcinoma, Ehrlich Tumor; Cell Membrane; Cell Nucleus; Daunorubicin; Drug Resistance; Etoposide; Phenotype; Polysorbates; Tumor Cells, Cultured; Verapamil | 1992 |
Effects of the lipophilic anticancer drug teniposide (VM-26) on membrane transport.
Topics: Amino Acids; Animals; Biological Transport; Carcinoma, Ehrlich Tumor; Carrier Proteins; Cell Membrane; Cell Membrane Permeability; Cytarabine; Etoposide; Humans; Membrane Lipids; Membranes, Artificial; Nucleosides; Podophyllotoxin; Teniposide; Tumor Cells, Cultured | 1990 |
Membrane ordering effects of the anticancer agent VM-26.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Carcinoma, Ehrlich Tumor; Cell Line; Cell Membrane; Cholesterol; Cyclic N-Oxides; Dimyristoylphosphatidylcholine; Electron Spin Resonance Spectroscopy; Etoposide; Humans; Leukemia; Lipid Bilayers; Liposomes; Male; Membrane Lipids; Mice; Podophyllotoxin; Spin Labels; Teniposide | 1986 |
Inhibition of 1-beta-D-arabinofuranosylcytosine transport and net accumulation by teniposide and etoposide in Ehrlich ascites cells and human leukemic blasts.
Topics: Animals; Binding Sites; Biological Transport; Carcinoma, Ehrlich Tumor; Cells, Cultured; Cytarabine; Etoposide; Humans; Leukemia; Male; Mice; Mice, Inbred Strains; Podophyllotoxin; Teniposide; Thioinosine; Tritium | 1985 |
[The antitumor activity of intraperitoneally- or orally-administered etoposide in animals and its administration-schedule dependency].
Topics: Adenocarcinoma; Administration, Oral; Animals; Carcinoma, Ehrlich Tumor; Colonic Neoplasms; Drug Administration Schedule; Etoposide; Female; Leukemia, Experimental; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mice; Neoplasms, Experimental; Podophyllotoxin | 1985 |